Tag Archives: FTC

Supreme Court Remands Pay-for-Delay Settlement for Antitrust Review in FTC v. Actavis

This post was also written by Jessica R. Rose. The U.S. Supreme Court last week issued a significant decision subjecting pay-for-delay settlements, a common practice in the pharmaceutical industry, to antitrust review. Also known as reverse payments, these settlements typically involve payments from a brand drug manufacturer to a generic drug manufacturer to settle patent litigation … Continue Reading

Supreme Court Reins in State-Action Immunity Doctrine

This post was written by William J. Sheridan. Yesterday, in FTC v. Phoebe Putney Health Systems, Inc., the Supreme Court rejected an expansive view of the state-action immunity doctrine articulated by the U.S. Court of Appeals for the Eleventh Circuit. Saying the court of appeals applied the doctrine’s concept of foreseeability “too loosely,” the unanimous … Continue Reading

Federal Trade Commission Announces Adjusted HSR Thresholds for 2013

On January 10, 2013, the Federal Trade Commission announced the annual threshold adjustments for premerger filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. § 18a) (“HSR”). The new thresholds have increased the dollar amount required to trigger HSR notification with respect to both the size-of-transaction and size-of-person tests. Please click here to … Continue Reading

Federal Trade Commission Announces Adjusted HSR Thresholds for 2012

On January 24, 2012, the Federal Trade Commission announced the annual threshold adjustments for premerger filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (15 U.S.C. § 18a) (“HSR”). The new thresholds have increased the dollar amount required to trigger HSR notification with respect to both the size-of-transaction and size-of-person tests. The revised HSR thresholds … Continue Reading
LexBlog